Applied Therapeutics

About Applied Therapeutics

Applied Therapeutics is a clinical-stage biopharmaceutical company focused on developing transformative treatments for patients with fatal or debilitating diseases. The company employs a novel drug development approach to target molecules and pathways with proven roles in these conditions. Applied Therapeutics operates in the biopharmaceutical market, primarily serving patients in need of life-changing treatments. The business model revolves around clinical trials and drug development, aiming to bring innovative therapies to market. Revenue is generated through the successful development and commercialization of these treatments, as well as potential partnerships and licensing agreements. The company's first molecular target is Aldose Reductase (AR), an enzyme implicated in diseases like Galactosemia and Diabetic Cardiomyopathy. By leveraging recent technological advances, Applied Therapeutics aims to design products with increased potency and selectivity, addressing previous efficacy and safety issues in AR inhibition.